FLUKIVER DIN 02449293
Health Canada record
| Active ingredient(s) | CLOSANTEL (CLOSANTEL SODIUM) 50 MG |
|---|---|
| Dosage form | Suspension |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 29-Sep-2016 |
| Current status date | 23-Feb-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19996 | 2017-11-01 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 17505 | 2015-11-24 | New Drug Submission (NDS) |